Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck announces US launch of ONTRUZANT, a biosimilar of Herceptin

pharmaceutical-business-reviewApril 20, 2020

Tag: Merck , Herceptin , Ontruzant

PharmaSources Customer Service